|
|
||||||||
The Journal of Immunology, Vol 144, Issue 9 3305-3311, Copyright © 1990 by American Association of Immunologists
ARTICLES |
WJ Murphy, V Kumar, JC Cope and M Bennett
Department of Pathology, University of Texas Southwestern Medical Center, Dallas 75235.
The mechanisms behind the increased incidence of marrow graft failure in recipients that receive allogeneic marrow depleted of T cells were studied. Recipient mice were lethally irradiated and challenged with bone marrow cells (BMC) from C.B-17 +/+ (+/+) donors. Radioisotope 125IUdR incorporation was assessed 5 to 7 days after transfer to determine the extent of engraftment. Some groups received BMC in which the T cells were removed by treatment with antibody and C. In addition, some groups received BMC from T cell-deficient C.B-17 scid/scid (SCID) mice to determine the postulated need for donor T cells in hematopoiesis and engraftment. In a model system that distinguishes between possible host NK cell and radioresistant T cell-mediated rejection of marrow allografts, it was determined that the absence of donor T cells in a marrow graft does not affect engraftment in syngeneic recipients. However, both host NK cell and radioresistant T cell rejection was markedly enhanced when SCID BMC or BMC from C.B-17 +/+ donors that had T cells removed by antibody and complement were infused into irradiated allogeneic recipients. Furthermore, the addition of alloreactive thymocytes as a source of T cells could abrogate this increased susceptibility of the BMC to host rejection mechanisms. As determined by histology and 59Fe uptake, the addition of thymocytes resulted in enhanced erythropoiesis. These results suggest that the increased incidence of marrow graft failure when BMC depleted of T cells are used is a result of active rejection by host effector cells and that the adverse effect of marrow T cell depletion can be reversed by the addition of thymocytes.
This article has been cited by other articles:
![]() |
K. Iizuka, A. A. Scalzo, H. Xian, and W. M. Yokoyama Regulation of the NK Cell Alloreactivity to Bone Marrow Cells by the Combination of the Host NK Gene Complex and MHC Haplotypes J. Immunol., March 1, 2008; 180(5): 3260 - 3267. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Barao, A. M. Hanash, W. Hallett, L. A. Welniak, K. Sun, D. Redelman, B. R. Blazar, R. B. Levy, and W. J. Murphy Suppression of natural killer cell-mediated bone marrow cell rejection by CD4+CD25+ regulatory T cells PNAS, April 4, 2006; 103(14): 5460 - 5465. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Barrett, K. Rezvani, S. Solomon, A. M. Dickinson, X. N. Wang, G. Stark, H. Cullup, M. Jarvis, P. G. Middleton, and N. Chao New Developments in Allotransplant Immunology Hematology, January 1, 2003; 2003(1): 350 - 371. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. R. Drobyski, H. C. Morse III, W. H. Burns, J. T. Casper, and G. Sandford Protection from lethal murine graft-versus-host disease without compromise of alloengraftment using transgenic donor T cells expressing a thymidine kinase suicide gene Blood, April 15, 2001; 97(8): 2506 - 2513. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-k. Lee, K. Kim, L. A. Welniak, W. J. Murphy, K. Muegge, and S. K. Durum Thymic emigrants isolated by a new method possess unique phenotypic and functional properties Blood, March 1, 2001; 97(5): 1360 - 1369. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Urbano-Ispizua, C. Rozman, P. Pimentel, C. Solano, J. de la Rubia, S. Brunet, J. Perez-Oteiza, C. Ferra, J. Zuazu, D. Caballero, et al. The number of donor CD3+ cells is the most important factor for graft failure after allogeneic transplantation of CD34+ selected cells from peripheral blood from HLA-identical siblings Blood, January 15, 2001; 97(2): 383 - 387. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. D. Shultz, P. A. Lang, S. W. Christianson, B. Gott, B. Lyons, S. Umeda, E. Leiter, R. Hesselton, E. J. Wagar, J. H. Leif, et al. NOD/LtSz-Rag1null Mice: An Immunodeficient and Radioresistant Model for Engraftment of Human Hematolymphoid Cells, HIV Infection, and Adoptive Transfer of NOD Mouse Diabetogenic T Cells J. Immunol., March 1, 2000; 164(5): 2496 - 2507. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Raziuddin, D. L. Longo, L. Mason, J. R. Ortaldo, M. Bennett, and W. J. Murphy Differential Effects of the Rejection of Bone Marrow Allografts by the Depletion of Activating Versus Inhibiting Ly-49 Natural Killer Cell Subsets J. Immunol., January 1, 1998; 160(1): 87 - 94. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |